External Advisory Board Bios
Click on the IOA External Advisory Board member's name below to learn more about each individual and the expertise he/she brings to the IOA.
Steven M. Paul, MD
Daniel P. Perry
Vivian Weyerhauser Piasecki
|
Executive Vice President, Science and Technology, President of Lilly Research Laboratories Steven M. Paul, MD, became executive vice president for science and technology and president of Lilly Research Laboratories, a division of Eli Lilly and Company, in July 2003. He also is a member of the corporate policy and strategy, operations committees and the company's senior management council, a group of top Lilly executives who implements corporate strategies, ensures corporate performance and identifies corporate issues and opportunities. He joined Lilly in April 1993 as vice president of central nervous system discovery and decision phase medical research in LRL and was named vice president, therapeutic area discovery research and clinical investigation, in 1996. Dr. Paul became group vice president of therapeutic area discovery research and clinical investigation for LRL in 1998. Dr. Paul received a bachelor of arts degree, magna cum laude with honors, in biology and psychology from Tulane University in 1972. He received a master of science degree in anatomy and neuroanatomy and his doctor of medicine degree, both in 1975, from the Tulane University School of Medicine. Following an internship in neurology at Charity Hospital in New Orleans, he served as a resident in psychiatry and an instructor in the department of psychiatry at The University of Chicago, Pritzker School of Medicine. Prior to joining Lilly, Dr. Paul served as scientific director of the Intramural Research Program of the National Institute of Mental Health (NIMH), in Bethesda, Md.; professor of psychiatry at Tulane University School of Medicine; and chief of the clinical neuroscience branch, as well as chief of the section on preclinical studies at the National Institute of Mental Health (NIMH). Dr. Paul is a member of various professional societies, which include the Tulane Scholars and Fellows; Phi Eta Sigma; Alpha Epsilon Delta; Sigma Xi; Phi Beta Kappa; and the Alpha Omega Alpha Medical Society. He is the recipient of many honors and scientific recognitions, including the A.E. Bennett Award of the Society of Biological Psychiatry, the Foundations' Fund Prize for Research of the American Psychiatric Association and The Distinguished Service Medal of the United States. In 1997, Paul was elected to membership in the Institute of Medicine of the National Academy of Sciences. Dr. Paul has authored or co-authored more than 500 papers and invited book chapters, and he was listed as one of the most highly cited neuroscientists in the world (1980-2000), by the Institute for Scientific Information (I.S.I.), Philadelphia, PA. He serves on the editorial boards of numerous scientific journals and on several NIH extramural and intramural committees. He also serves on the executive board of PhRMA's Science and Regulatory Committee and is the incoming chairperson. Paul serves on the board of directors of the Lilly Foundation, the Foundation of the NIH, Butler University and the Indianapolis Zoological Society. He is currently a member of the National Institute of Health's advisory committee to the director (ACD). |
Back to External Advisory Board main page
|
Executive Director Mr. Perry's background spans a wide range of health policy, governmental, political and journalistic experience. Mr. Perry held staff positions for more than a dozen years on Capitol Hill, including special assistant to the Majority Whip of the U.S. Senate. He was appointed by Health and Human Services Secretary Louis Sullivan during the first Bush Administration to the Federal Task Force on Aging Research. He was also named by President Clinton as an advisor to the White House Conference on Aging. As part of the influential Jackson Hole Group on healthcare issues, Mr. Perry helped establish the groundwork for the Foundation for Accountability, or FACCT. He currently serves as Chairman of the FACCT Board of Directors. Mr. Perry was selected to represent consumer interests on the first governing body of the American Medical Accreditation Program (AMAP), assessing credentials and performance of U.S. physicians. He is a Director of the Institute for Advanced Studies in Immunology and Geriatric Medicine in Washington, D.C., and a member of the New York Academy of Sciences. Mr. Perry is a frequent speaker on aging research and public policy topics before business, academic, and public sector audiences, and is widely published on these subjects. As a journalist he was the recipient of many awards and citations, including a nomination for the Pulitzer Prize. He is also Co-Chair of the newly-formed coalition, Friends of the National Institute on Aging (FoNIA), a group supporting and promoting the NIA, its research efforts and training mission. |
Back to External Advisory Board main page
| A graduate of Vassar College and the New York School of Design, Vivian Weyerhaeuser Piasecki has contributed her creativity and philanthropic spirit as a longtime member of the IOA’s External Advisory Board. President of the Piasecki Family Foundation and active with the Weyerhaeuser Family Foundation, Ms. Piasecki has served on numerous corporate boards, both locally and nationally, while maintaining her personal commitment to community involvement and service here in Philadelphia. Ms. Piasecki has served as a Trustee of the University of Pennsylvania, as Chairperson of the Board of Overseers of the Penn School of Nursing, and on the board of the University of Pennsylvania Medical Center. In addition to her tenure as a member of the IOA’s External Advisory Board, she currently participates as a senior board member for WHYY, Inc. and One to One - The Greater Mentoring Partnership. Ms. Piasecki also has been integral in the development of the National Constitution Center, co-chairing the Center’s Capital Campaign, which made the Center a reality, and serving as a member of the board and the executive committee. |
Back to External Advisory Board main page